中文名称: | BIX 01294 促销 | ||||
---|---|---|---|---|---|
英文名称: | BIX 01294 | ||||
别名: | 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-Quinazolinamine | ||||
CAS No: | 1392399-03-9 | 分子式: | C28H38N6O2.3HCl | 分子量: | 600.02 |
CAS No: | 1392399-03-9 | ||||
分子式: | C28H38N6O2.3HCl | ||||
分子量: | 600.02 |
基本信息
产品编号:B10032 |
|||||
产品名称:BIX 01294 |
|||||
CAS: |
1392399-03-9 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
分子量: |
600.02 |
-20℃ |
一个月 |
||
化学名: |
|
||||
Solubility (25°C) |
体外 |
DMSO |
100mg/mL (166.66mM) |
||
Ethanol |
100mg/mL (166.66mM) |
||||
Water |
100mg/mL (166.66mM) |
||||
体内(现配现用) |
|
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
1.6666mL |
8.3331mL |
16.6661mL |
5mM |
0.3333mL |
1.6666mL |
3.3332mL |
10mM |
0.1667mL |
0.8333mL |
1.6666mL |
50mM |
0.0333mL |
0.1667mL |
0.3333mL |
生物活性
产品描述 |
一种选择性的组蛋白甲基转移酶(HMTASE)抑制剂。 |
|
靶点/IC50 |
G9a |
|
2.7μM |
||
体外研究 |
BIX-01294 (2μM;48h) selectively inhibits recurrent tumor cell growth.BIX-01294 (1μM) leads to a marked increase in phosphorylation of S345 of MLKL.BIX-01294 (1μM) significantly upregulates the canonical p53 targets Cdkn1a (p21) and Gadd45a in recurrent tumor cell lines.BIX-01294 (1μM;6 days) causes the reduction in H3K9me2 levels in primary and recurrent tumor cells.BIX-01294 leads to necroptotic cell death in recurrent tumor cells.Necrostatin-1 (30μM) partially reverses cell death induced by BIX-01294 (750nM;24h).BIX-01294 (4.1μM;for 2 days) causes around a 20% reduction,concomitant with a comparable increase in the unmodified H3K9 fragment in H3K9me2 in mouse ES cells.BIX-01294 causes pronounced reduction in H3K9me2 and a small decrease for H3K9me3 and H3K9me1 in wild-type ES cells.BIX-01294 has no inhibition of the other histone methyltransferases even at concentrations of 45μM.BIX-01294 does not affect SUV39H1 (H320R) and PRMT1 within the tested concentration range (up to 10μM).BIX-01294 inhibits G9a in an uncompetitive manner with S-adenosyl-methionine (SAM).BIX-01294 (1µg/mL) causes reduction in the BrdU incorporation of fetal PASMCs.BIX-01294 treatment decreases the PASMCs migration induced by PDGF. |
|
Cell Line: |
Primary or recurrent tumor cells |
|
Concentration: |
2μM |
|
Incubation Time: |
48 hours |
|
Result: |
Selectively inhibited recurrent tumor cell growth. |
|
体内研究 |
BIX-01294 (10mg/kg; IP;three times a week for 2 weeks) significantly reduces tumor growth and tumor burden in recurrent tumor cells.Primary tumor growth is not inhibited. |
|
Animal Model: |
Female MMTV-rtTA;TetO-Her2/neu (MTB;TAN) and TetO-Her2/neu (TAN) mice with recurrent or primary tumor cells. |
|
Dosage: |
10mg/kg |
|
Administration: |
IP;three times a week for 2 weeks |
|
Result: |
Significantly reduced tumor growth and tumor burden in recurrent tumor cells.Primary tumor growth was not inhibited. Slowed the growth of orthotopic recurrent tumors in athymic nude recipients. |
推荐实验方法(仅供参考)
激酶实验: |
|
HMTase实验 |
在涂有Neutravidin的白色不透明384孔板中进行解离增强镧系荧光免疫分析(DELFIA)。实验化合物在含4% DMSO的12μg/ml 50mM Tris-HCl pH 8.5中稀释,每孔分配10μl。空白和对照孔只有化合物缓冲液。10μg/ml GST-G9a和40μM SAM在50mM Tris HCl pH 8.5/10mM DTT 中稀释,然后加入20μL。空白孔只有Tris/DTT缓冲液。加入溶于50mM Tris pH 8.5,体积为10μl的800nM H3(1-20)-cysbiotin 底物,开始反应,在室温下温育60分钟。使用100μl 洗涤缓冲液洗涤实验板3次。然后实验板的每孔中加入含5ng α-2X-二甲基-H3-K9 和 5ng 山羊抗兔Eu螯合物的50μl 荧光免疫(FI) 缓冲液,在室温下再温育1小时。使用100μl洗涤缓冲液 洗涤实验板3次,每孔加入50μl增强液。45分钟后在Viewlux微孔板成像仪成像15秒,测量时间分辨荧光。 |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )